By Mehryar Behizad2023-12-05T16:00:00
Richard Vincins outlined how post-market surveillance (PMS) is becoming increasingly important around the world in many jurisdictions. Previously, PMS activities used to be concentrated on vigilance and complaints, however the Medical Device Regulation (MDR) explicitly identifies sources of data which have not previously been properly identified or evaluated. Even if these are identified, the evaluation and analysis of their data was lacking in detail and methodology.
Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.
Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.
LoginBecome a TOPRA member and join our global regulatory affairs community.
The peer-reviewed journal, published 11 times per year and available free to TOPRA members.
The Organisation for Professionals in Regulatory Affairs
TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org
TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70
Site powered by Webvision Cloud